CoChat

Stress, the Autonomic Nervous System, and the Immune-kynurenine Pathway in the Etiology of Depression

Open access
Won, Eunsoo, Kim, Yong-Ku · 2016 · Current Neuropharmacology

The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.

Abstract

The autonomic nervous system is one of the major neural pathways activated by stress. In situations that are often associated with chronic stress, such as major depressive disorder, the sympathetic nervous system can be continuously activated without the normal counteraction of the parasympathetic nervous system. As a result, the immune system can be activated with increased levels of proinflammatory cytokines. These inflammatory conditions have been repeatedly observed in depression. In the search for the mechanism by which the immune system might contribute to depression, the enhanced activity of indoleamine 2,3- dioxygenase by pro-inflammatory cytokines has been suggested to play an important role. Indoleamine 2,3-dioxygenase is the first enzyme in the kynurenine pathway that converts tryptophan to kynurenine. Elevated activity of this enzyme can cause imbalances in downstream kynurenine metabolites. This imbalance can induce neurotoxic changes in the brain and create a vulnerable glial-neuronal network, which may render the brain susceptible to depression. This review focuses on the interaction between stress, the autonomic nervous system and the immune system which can cause imbalances in the kynurenine pathway, which may ultimately lead to major depressive disorder.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/1570159x14666151208113006

Cites

109 of 109 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. (1) The interaction between stress, the autonomic nervous system, the immune system and the kynurenine pathway in the etiology of depression. The hypothalamus secretes CRH in response to stress, and from the paraventricular nucleus of the hypothalamus, CRH-containing neurons have projections to the locus coeruleus. The locus coeruleus sends direct projections to the sympathetic and parasympathetic preganglionic neurons, increasing sympathetic activity and decreasing parasympathetic activity through the activation of adrenoceptors. In turn, the activation of the sympathetic nervous system stimulates the release of CRH. When stress is prolonged, as in major depressive disorder, the sympathetic nervous system continues to be activated, with a lack of parasympathetic counter activity. As a result, NE and E levels are increased and ACh levels are decreased, which lead to an increased release of pro-inflammatory cytokines from immune cells. Pro-inflammatory cytokines, such as TNF, IL-1, IL-6 and interferons can induce IDO activity, which increases the KYN/tryptophan ratio. As a result, downstream metabolites, such as 3-hydroxykynurenine, 3-hydroxyanthranilic acid and quinolinic acid are increased, which all have neurotoxic effects on the brain. 3-hydroxykynurenine generates free-radicals and causes neuronal apoptosis. 3-hydroxyanthranilic acid generates highly reactive hydrogen peroxide and hydroxyl radicals. Quinolinic acid selectively activates N-methyl-d-aspartate (NMDA) receptors, and high concentrations of extracellular glutamate and persistent activation of excitatory neurons cause excitotoxicity. Therefore, the accumulation of quinolinic acid can result in neuronal excitotoxicity and the selective apoptosis of astrocytes. This can ultimately lead to neurodegenerative changes, which may render the brain susceptible to depression.
Fig. (1) The interaction between stress, the autonomic nervous system, the immune system and the kynurenine pathway in the etiology of depression. The hypothalamus secretes CRH in response to stress, and from the paraventricular nucleus of the hypothalamus, CRH-containing neurons have projections to the locus coeruleus. The locus coeruleus sends direct projections to the sympathetic and parasympathetic preganglionic neurons, increasing sympathetic activity and decreasing parasympathetic activity through the activation of adrenoceptors. In turn, the activation of the sympathetic nervous system stimulates the release of CRH. When stress is prolonged, as in major depressive disorder, the sympathetic nervous system continues to be activated, with a lack of parasympathetic counter activity. As a result, NE and E levels are increased and ACh levels are decreased, which lead to an increased release of pro-inflammatory cytokines from immune cells. Pro-inflammatory cytokines, such as TNF, IL-1, IL-6 and interferons can induce IDO activity, which increases the KYN/tryptophan ratio. As a result, downstream metabolites, such as 3-hydroxykynurenine, 3-hydroxyanthranilic acid and quinolinic acid are increased, which all have neurotoxic effects on the brain. 3-hydroxykynurenine generates free-radicals and causes neuronal apoptosis. 3-hydroxyanthranilic acid generates highly reactive hydrogen peroxide and hydroxyl radicals. Quinolinic acid selectively activates N-methyl-d-aspartate (NMDA) receptors, and high concentrations of extracellular glutamate and persistent activation of excitatory neurons cause excitotoxicity. Therefore, the accumulation of quinolinic acid can result in neuronal excitotoxicity and the selective apoptosis of astrocytes. This can ultimately lead to neurodegenerative changes, which may render the brain susceptible to depression.CC BY-NC · PubMed Central
Fig. (2) IDO and kynurenine monooxygenase activity are enhanced by pro-inflammatory cytokines, and as a result the balance between the formation of 3-hydroxykynurenine and of kynurenic acid is shifted to the side of 3-hydroxykynurenine, which forms 3-hydroxyanthranilic acid and finally quinolinic acid. As KYN synthesized in the periphery can also penetrate the brain, KYN pathway metabolism in the brain is also initiated by KYN that crosses the blood brain barrier. KYN and 3-hydroxykynurenine easily cross the BBB, whereas quinolinic acid and kynurenic acid crosses the BBB poorly. The 3-hydroxykynurenine arm of the pathway leading to quinolinic acid production takes place in microglia, and kynurenic acid production takes place in astrocytes. The KYN pathway in the microglia can be enhanced in inflammatory conditions, as kynurenine monooxygenase activity is enhanced by pro-inflammatory cytokines. Immune responses can also activate microglia and cause an influx of macrophages into the brain, which causes a significant increase in quinolinic acid synthesis.
Fig. (2) IDO and kynurenine monooxygenase activity are enhanced by pro-inflammatory cytokines, and as a result the balance between the formation of 3-hydroxykynurenine and of kynurenic acid is shifted to the side of 3-hydroxykynurenine, which forms 3-hydroxyanthranilic acid and finally quinolinic acid. As KYN synthesized in the periphery can also penetrate the brain, KYN pathway metabolism in the brain is also initiated by KYN that crosses the blood brain barrier. KYN and 3-hydroxykynurenine easily cross the BBB, whereas quinolinic acid and kynurenic acid crosses the BBB poorly. The 3-hydroxykynurenine arm of the pathway leading to quinolinic acid production takes place in microglia, and kynurenic acid production takes place in astrocytes. The KYN pathway in the microglia can be enhanced in inflammatory conditions, as kynurenine monooxygenase activity is enhanced by pro-inflammatory cytokines. Immune responses can also activate microglia and cause an influx of macrophages into the brain, which causes a significant increase in quinolinic acid synthesis.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 109 references

Cited by

See all 330

Metadata

Authors
Won, E., & Kim, Y.-K.
Affiliations
  • Korea University (KR)
  • Korea University Ansan Hospital (KR)
Corresponding author
Kim, Yong-Ku
Venue
Current Neuropharmacology
Published
2016-08-26
Volume
14
Issue
7
Pages
665-673
ISSN
1570-159X (ISSN-L)
OpenAlex
W2312140404
Cited by
300
References
109
Citations by year
2026: 16 · 2025: 35 · 2024: 39 · 2023: 55 · 2022: 49 · 2021: 46 · 2020: 21 · 2019: 17 · 2018: 10 · 2017: 8 · 2016: 4
FWCI
0.78
Type
journal article
Language
en
Open access
Locations
  • Current Neuropharmacology (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
depression, chronic stress, autonomic nervous system, sympathetic nervous system, parasympathetic nervous system, indoleamine 2,3-dioxygenase, kynurenine metabolites, inflammatory cytokines, neuroinflammation, tryptophan metabolism, neurotoxicity
MeSH terms
Animals, Autonomic Nervous System, Major Depressive Disorder, Depressive Disorder, Major, Humans, Kynurenine, Stress, Psychological, Tryptophan

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Stress, the Autonomic Nervous System, and the Immune-kynurenine Pathway in the Etiology of Depression. https://app.cochat.ai/papers/10.2174/1570159x14666151208113006
The paper
Won, E., & Kim, Y.-K. (2016). Stress, the Autonomic Nervous System, and the Immune-kynurenine Pathway in the Etiology of Depression. Current Neuropharmacology. https://doi.org/10.2174/1570159x14666151208113006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.